Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody
Date
2017-04-03
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
SpringerNature
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
We have utilized a high-diversity phage display library to engineer antibody fragments (Fabs) that can modulate the activity of the enzyme isocitrate dehydrogenase 1 (IDH1). We show that a conformation-specific Fab can reactivate an IDH1 mutant associated with brain tumors. The results show that this strategy is a first step towards developing "activator drugs" for a large number of genetic disorders where mutations have disrupted protein function.
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Rizk, S. S., Mukherjee, S., Koide, A., Koide, S., & Kossiakoff, A. A. (2017). Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody. Scientific Reports, 7, 556. http://doi.org/10.1038/s41598-017-00728-1
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Scientific Reports
Source
PMC
Alternative Title
Type
Article